Search research articles
Contact Us
Filters
Showing results (101-110 of 226) with videos related to
Page
of 23
Sort By:
Chest
|
June 1, 1987
Hemoptysis as the presenting manifestation of sarcoidosis
I Rubinstein, G L Baum, Y Hiss, et al.
Pharmaceutical Research
|
March 1, 1997
Development of a novel bioactive formulation of vasoactive intestinal peptide in sterically stabilized liposomes
F Séjourné, I Rubinstein, H Suzuki, et al.
Infection and Immunity
|
February 13, 2001
Mechanisms mediating Porphyromonas gingivalis gingipain RgpA-induced oral mucosa inflammation in vivo
I Rubinstein, J Potempa, J Travis, et al.
Southern Medical Journal
|
September 1, 1985
Sarcoidosis: a cause of bilateral hilar lymphadenopathy after excision of malignant melanoma of the arm
I Rubinstein, G L Baum, A Yellin, et al.
Progress in Neuro-Psychopharmacology
|
January 1, 1979
Dopamine-beta-hydroxylase activity in serum of patients with hepatic damage
R Rabinowitz, A D Korczyn, Y Eshel, et al.
Lancet (London, England)
|
October 29, 1988
Determinants of blood pressure in snorers
V Hoffstein, I Rubinstein, S Mateika, et al.
European Journal of Respiratory Diseases
|
April 1, 1985
Hemoptysis in sarcoidosis
I Rubinstein, G L Baum, Y Hiss, et al.
Life Sciences
|
January 1, 1994
Vasoactive intestinal peptide encapsulated in liposomes: effects on systemic arterial blood pressure
X P Gao, Y Noda, I Rubinstein, et al.
The Journal of Clinical Investigation
|
April 1, 1988
Paradoxical glottic narrowing in patients with severe obstructive sleep apnea
I Rubinstein, A S Slutsky, N Zamel, et al.
Chest
|
July 1, 1988
Neurosarcoidosis associated with hypersomnolence treated with corticosteroids and brain irradiation
I Rubinstein, T A Gray, H Moldofsky, et al.
Page
of 23
Search research articles
Search
Showing results (101-110 of 226) with videos related to
Sort By:
Page
of 23
Chest
|
June 1, 1987
Hemoptysis as the presenting manifestation of sarcoidosis
I Rubinstein, G L Baum, Y Hiss, et al.
Pharmaceutical Research
|
March 1, 1997
Development of a novel bioactive formulation of vasoactive intestinal peptide in sterically stabilized liposomes
F Séjourné, I Rubinstein, H Suzuki, et al.
Infection and Immunity
|
February 13, 2001
Mechanisms mediating Porphyromonas gingivalis gingipain RgpA-induced oral mucosa inflammation in vivo
I Rubinstein, J Potempa, J Travis, et al.
Southern Medical Journal
|
September 1, 1985
Sarcoidosis: a cause of bilateral hilar lymphadenopathy after excision of malignant melanoma of the arm
I Rubinstein, G L Baum, A Yellin, et al.
Progress in Neuro-Psychopharmacology
|
January 1, 1979
Dopamine-beta-hydroxylase activity in serum of patients with hepatic damage
R Rabinowitz, A D Korczyn, Y Eshel, et al.
Lancet (London, England)
|
October 29, 1988
Determinants of blood pressure in snorers
V Hoffstein, I Rubinstein, S Mateika, et al.
European Journal of Respiratory Diseases
|
April 1, 1985
Hemoptysis in sarcoidosis
I Rubinstein, G L Baum, Y Hiss, et al.
Life Sciences
|
January 1, 1994
Vasoactive intestinal peptide encapsulated in liposomes: effects on systemic arterial blood pressure
X P Gao, Y Noda, I Rubinstein, et al.
The Journal of Clinical Investigation
|
April 1, 1988
Paradoxical glottic narrowing in patients with severe obstructive sleep apnea
I Rubinstein, A S Slutsky, N Zamel, et al.
Chest
|
July 1, 1988
Neurosarcoidosis associated with hypersomnolence treated with corticosteroids and brain irradiation
I Rubinstein, T A Gray, H Moldofsky, et al.
Page
of 23